Term: Acute coronary syndrome
Accession: HP:0033678
browse the term
Definition: The term acute coronary syndrome (ACS) refers to any group of clinical symptoms compatible with acute myocardial ischemia and includes unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI).
Comment: A diagnosis of NSTEMI can be made when the ischemia is sufficiently severe to cause myocardial damage that results in the release of a biomarker of myocardial necrosis into the circulation (cardiac-specific troponins T or I, or muscle and brain fraction of creatine kinase [CK-MB]). In contrast, the patient is considered to have experienced UA if no such biomarker can be detected in the bloodstream hours after the initial onset of ischemic chest pain. Unstable angina exhibits 1 or more of 3 principal presentations: (1) rest angina (usually lasting >20 minutes), (2) new-onset (<2 months previously) severe angina, and (3) a crescendo pattern of occurrence (increasing in intensity, duration, frequency, or any combination of these factors).
Synonyms: xref: EFO:0005672
G
CCN1
cellular communication network factor 1
susceptibility
IAGP
DNA:SNP,haplotypes:5'utr: (rs6576776) (human)
RGD
PMID:33906697
RGD:329845569
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
IAGP
ClinVar Annotator: match by term: Acute coronary syndrome
ClinVar
PMID:7969038 PMID:9093256 PMID:19444287 PMID:21270786 PMID:27441996
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
OGG1
8-oxoguanine DNA glycosylase
susceptibility
IAGP
DNA:SNP,haplotype: :p.S326C (rs1052133) (human)
RGD
PMID:23368530
RGD:401827273
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
G
ABCA1
ATP binding cassette subfamily A member 1
IAGP
HPO
MIM:205400 MIM:604091
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCC6
ATP binding cassette subfamily C member 6
IAGP
HPO
MIM:614473
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
G
ABCC9
ATP binding cassette subfamily C member 9
IAGP
ClinVar Annotator: match by term: Myocardial infarction
ClinVar HPO
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
ORPHA:334
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ABCG5
ATP binding cassette subfamily G member 5
IAGP
HPO
ORPHA:391665
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABCG8
ATP binding cassette subfamily G member 8
IAGP
HPO
ORPHA:391665
NCBI chr 2:43,838,971...43,882,988
Ensembl chr 2:43,831,942...43,882,988
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
IAGP
HPO
MIM:274150
NCBI chr 9:133,414,337...133,459,386
Ensembl chr 9:133,414,358...133,459,402
G
ADD1
adducin 1
no_association
IAGP
DNA:missense mutation:cds:p.G460W DNA:missense mutation:cds:p.G460W
RGD
PMID:16420563 PMID:17082469
RGD:5148001 , RGD:5147995
NCBI chr 4:2,843,844...2,930,062
Ensembl chr 4:2,843,844...2,930,076
G
ADRB3
adrenoceptor beta 3
susceptibility
IAGP
associated with Diabetes Mellitus, Type 2;DNA:missense mutation:cds:p.W64R (rs4994)
RGD
PMID:20536507
RGD:5684776
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
APOA4
apolipoprotein A4
susceptibility
IAGP
DNA:missense mutation:cds:p.T347S
RGD
PMID:12676816
RGD:1578411
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
APOB
apolipoprotein B
IAGP
HPO
ORPHA:391665
NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
G
APOE
apolipoprotein E
IAGP
DNA:missense mutations, haplotype:cds:p.C112R, p.C158R
RGD
PMID:10090925
RGD:10449412
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
ATRX
ATRX chromatin remodeler
IAGP
HPO
ORPHA:96253
NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233
G
BAZ1B
bromodomain adjacent to zinc finger domain 1B
IAGP
HPO
ORPHA:904
NCBI chr 7:73,440,406...73,522,293
Ensembl chr 7:73,440,406...73,522,293
G
BCHE
butyrylcholinesterase
IAGP
HPO
ORPHA:132
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
IAGP
HPO
ORPHA:500 ORPHA:54595 ORPHA:96253
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
BUD23
BUD23 rRNA methyltransferase and ribosome maturation factor
IAGP
HPO
ORPHA:904
NCBI chr 7:73,683,597...73,698,212
Ensembl chr 7:73,683,597...73,698,212
G
C4A
complement C4A (Chido/Rodgers blood group)
IAGP
HPO
ORPHA:117
NCBI chr 6:31,982,057...32,002,681
Ensembl chr 6:31,982,057...32,002,681
G
CALR
calreticulin
IAGP
HPO
ORPHA:3318
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CBS
cystathionine beta-synthase
IAGP
HPO
MIM:236200
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
G
CCND1
cyclin D1
IAGP
HPO
ORPHA:892
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCR1
C-C motif chemokine receptor 1
IAGP
HPO
ORPHA:117
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CDH23
cadherin related 23
IAGP
HPO
ORPHA:96253
NCBI chr10:71,396,920...71,815,947
Ensembl chr10:71,396,920...71,815,947
G
CELA2A
chymotrypsin like elastase 2A
IAGP
HPO
MIM:618620
NCBI chr 1:15,456,732...15,472,091
Ensembl chr 1:15,456,728...15,472,091
G
CEP19
centrosomal protein 19
IAGP
HPO
MIM:615703
NCBI chr 3:196,706,277...196,712,250
Ensembl chr 3:196,706,277...196,712,250
G
CFTR
CF transmembrane conductance regulator
IAGP
HPO
ORPHA:60033
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CLIP2
CAP-Gly domain containing linker protein 2
IAGP
HPO
ORPHA:904
NCBI chr 7:74,289,407...74,405,935
Ensembl chr 7:74,289,407...74,405,935
G
CTNNB1
catenin beta 1
IAGP
HPO
ORPHA:54595
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
IAGP
HPO
MIM:213700
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2R1
cytochrome P450 family 2 subfamily R member 1
IAGP
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr11:14,877,440...14,892,443
Ensembl chr11:14,877,440...14,892,231
G
DNAJC30
DnaJ heat shock protein family (Hsp40) member C30
IAGP
HPO
ORPHA:904
NCBI chr 7:73,680,918...73,683,453
Ensembl chr 7:73,680,918...73,683,453
G
DYRK1B
dual specificity tyrosine phosphorylation regulated kinase 1B
IAGP
HPO
MIM:615812
NCBI chr19:39,825,350...39,834,162
Ensembl chr19:39,825,350...39,834,201
G
EIF4H
eukaryotic translation initiation factor 4H
IAGP
HPO
ORPHA:904
NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122
G
ELN
elastin
IAGP
HPO
ORPHA:904
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
G
ENPP1
ectonucleotide pyrophosphatase/phosphodiesterase 1
IAGP
HPO
MIM:208000
NCBI chr 6:131,808,020...131,895,155
Ensembl chr 6:131,808,016...131,895,155
G
EPOR
erythropoietin receptor
IAGP
HPO
MIM:133100
NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
G
ERAP1
endoplasmic reticulum aminopeptidase 1
IAGP
HPO
ORPHA:117
NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100
G
FAS
Fas cell surface death receptor
IAGP
HPO
ORPHA:117
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FKBP6
FKBP prolyl isomerase family member 6 (inactive)
IAGP
HPO
ORPHA:904
NCBI chr 7:73,328,161...73,358,625
Ensembl chr 7:73,328,161...73,358,637
G
GATA4
GATA binding protein 4
IAGP
HPO
ORPHA:334
NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
G
GATA5
GATA binding protein 5
IAGP
HPO
ORPHA:334
NCBI chr20:62,463,497...62,475,995
Ensembl chr20:62,463,497...62,475,995
G
GATA6
GATA binding protein 6
IAGP
HPO
ORPHA:334
NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
G
GJA5
gap junction protein alpha 5
IAGP
HPO
ORPHA:334
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
G
GLA
galactosidase alpha
IAGP
HPO
MIM:301500
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GP6
glycoprotein VI platelet
onset no_association sexual_dimorphism ameliorates susceptibility
IAGP
DNA:missense mutation:CDS:c.13254T>C (p.S219P) DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) DNA:missense mutation:CDS:p.S219P (rs1613662) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P)
RGD
PMID:11571236 PMID:20723028 PMID:20227257 PMID:20227257 PMID:12417295 PMID:11571236 PMID:11571236 More...
RGD:401793749 , RGD:401794407 , RGD:401794138 , RGD:401794138 , RGD:401793754 , RGD:401793749 , RGD:401793749
NCBI chr19:55,013,705...55,038,264
Ensembl chr19:55,013,705...55,038,264
G
GTF2I
general transcription factor IIi
IAGP
HPO
ORPHA:904
NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692
G
GTF2IRD1
GTF2I repeat domain containing 1
IAGP
HPO
ORPHA:904
NCBI chr 7:74,453,906...74,602,605
Ensembl chr 7:74,453,790...74,602,605
G
GTF2IRD2
GTF2I repeat domain containing 2
IAGP
HPO
ORPHA:904
NCBI chr 7:74,796,151...74,851,605
Ensembl chr 7:74,796,151...74,851,605
G
HGD
homogentisate 1,2-dioxygenase
IAGP
HPO
ORPHA:56
NCBI chr 3:120,628,172...120,682,239
Ensembl chr 3:120,628,172...120,682,269
G
HLA-B
major histocompatibility complex, class I, B
IAGP
HPO
ORPHA:117 ORPHA:3287 ORPHA:36426
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
IDH2
isocitrate dehydrogenase (NADP(+)) 2
IAGP
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
IFNGR1
interferon gamma receptor 1
IAGP
HPO
ORPHA:117
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
G
IKZF1
IKAROS family zinc finger 1
IAGP
HPO
ORPHA:36426
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
IL10
interleukin 10
IAGP
HPO
ORPHA:117
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
IAGP
HPO
ORPHA:117
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL12A-AS1
IL12A antisense RNA 1
IAGP
HPO
ORPHA:117
NCBI chr 3:159,913,400...160,207,092
Ensembl chr 3:159,902,045...160,226,966
G
IL12B
interleukin 12B
IAGP
HPO
ORPHA:3287
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL23R
interleukin 23 receptor
IAGP
HPO
ORPHA:117
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IRF4
interferon regulatory factor 4
IAGP
HPO
ORPHA:3452
NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
G
JAK2
Janus kinase 2
IAGP
HPO
MIM:133100 ORPHA:3318
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KCNA5
potassium voltage-gated channel subfamily A member 5
IAGP
HPO
ORPHA:334
NCBI chr12:5,043,879...5,046,788
Ensembl chr12:5,043,879...5,046,788
G
KCNE1
potassium voltage-gated channel subfamily E regulatory subunit 1
IAGP
HPO
ORPHA:334
NCBI chr21:34,446,688...34,512,210
Ensembl chr21:34,446,688...34,512,214
G
KCNE2
potassium voltage-gated channel subfamily E regulatory subunit 2
IAGP
HPO
ORPHA:334
NCBI chr21:34,364,006...34,371,381
Ensembl chr21:34,180,729...34,371,381
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
IAGP
HPO
ORPHA:334
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KCNJ3
potassium inwardly rectifying channel subfamily J member 3
IAGP
HPO
ORPHA:334
NCBI chr 2:154,698,695...154,858,354
Ensembl chr 2:154,697,855...154,858,354
G
KCNJ5
potassium inwardly rectifying channel subfamily J member 5
IAGP
HPO
ORPHA:334
NCBI chr11:128,891,356...128,921,163
Ensembl chr11:128,891,356...128,921,163
G
KCNN4
potassium calcium-activated channel subfamily N member 4
susceptibility
IAGP
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
KCNQ1
potassium voltage-gated channel subfamily Q member 1
IAGP
HPO
ORPHA:334
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
G
KLRC4
killer cell lectin like receptor C4
IAGP
HPO
ORPHA:117
NCBI chr12:10,407,384...10,409,757
Ensembl chr12:10,403,059...10,409,757
G
LDLR
low density lipoprotein receptor
IAGP
HPO
ORPHA:391665
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LDLRAP1
low density lipoprotein receptor adaptor protein 1
IAGP
HPO
ORPHA:391665
NCBI chr 1:25,543,606...25,590,400
Ensembl chr 1:25,543,604...25,591,200
G
LIMK1
LIM domain kinase 1
IAGP
HPO
ORPHA:904
NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525
G
LMNA
lamin A/C
IAGP
HPO
MIM:176670 ORPHA:740
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081
G
LPL
lipoprotein lipase
IAGP
HPO
MIM:144250
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRP6
LDL receptor related protein 6
IAGP
HPO
MIM:610947
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
LTA
lymphotoxin alpha
severity
IAGP
DNA:SNP:exon:804C>A (p.T26N)
RGD
PMID:23398946
RGD:8548841
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MEF2A
myocyte enhancer factor 2A
IAGP
HPO
MIM:608320
NCBI chr15:99,565,417...99,716,488
Ensembl chr15:99,565,417...99,716,488
G
MEFV
MEFV innate immunity regulator, pyrin
IAGP
HPO
ORPHA:117 ORPHA:342
NCBI chr16:3,242,027...3,256,633
Ensembl chr16:3,242,027...3,256,633
G
METTL27
methyltransferase like 27
IAGP
HPO
ORPHA:904
NCBI chr 7:73,834,590...73,842,516
Ensembl chr 7:73,834,590...73,842,516
G
MLX
MAX dimerization protein MLX
IAGP
HPO
ORPHA:3287
NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239
G
MPL
MPL proto-oncogene, thrombopoietin receptor
IAGP
HPO
ORPHA:3318
NCBI chr 1:43,337,818...43,354,466
Ensembl chr 1:43,337,818...43,354,466
G
MTHFR
methylenetetrahydrofolate reductase
IAGP
DNA:SNP: :677C>T
RGD
PMID:10090925
RGD:10449412
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
MYH7
myosin heavy chain 7
IAGP
HPO
ORPHA:1880
NCBI chr14:23,412,740...23,435,660
Ensembl chr14:23,412,740...23,435,660
G
MYH9
myosin heavy chain 9
IAGP
HPO
MIM:155100 ORPHA:182050
NCBI chr22:36,281,280...36,387,967
Ensembl chr22:36,281,280...36,388,010
G
MYL4
myosin light chain 4
IAGP
HPO
ORPHA:334
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
G
NCF1
neutrophil cytosolic factor 1
IAGP
HPO
ORPHA:904
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NKX2-5
NK2 homeobox 5
IAGP
HPO
ORPHA:334
NCBI chr 5:173,232,109...173,235,206
Ensembl chr 5:173,232,109...173,235,311
G
NKX2-6
NK2 homeobox 6
IAGP
HPO
ORPHA:334
NCBI chr 8:23,701,740...23,706,756
Ensembl chr 8:23,701,740...23,706,756
G
NPPA
natriuretic peptide A
IAGP
HPO
ORPHA:334
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NR1H3
nuclear receptor subfamily 1 group H member 3
susceptibility
IAGP
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015)
RGD
PMID:21903943
RGD:401842365
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
NR3C1
nuclear receptor subfamily 3 group C member 1
IAGP
HPO
ORPHA:96253
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NUP155
nucleoporin 155
IAGP
HPO
ORPHA:334
NCBI chr 5:37,288,137...37,371,106
Ensembl chr 5:37,288,137...37,371,124
G
PCSK2
proprotein convertase subtilisin/kexin type 2
IAGP
DNA:SNP:intron: (rs6080699)
RGD
PMID:20036365
RGD:6483554
NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578
G
PCSK9
proprotein convertase subtilisin/kexin type 9
IAGP
HPO
ORPHA:391665
NCBI chr 1:55,039,548...55,064,852
Ensembl chr 1:55,039,445...55,064,852
G
PHACTR1
phosphatase and actin regulator 1
susceptibility severity no_association
IAGP
DNA:SNP:intron:g.13035530G>C (rs12526453) DNA:SNP:intron: (rs9369640) DNA:SNPs:multiple DNA:SNP:intron:(rs12526453) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300)
RGD
PMID:19198609 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763
RGD:401851907 , RGD:11052994 , RGD:11052493 , RGD:11056926 , RGD:401900171
NCBI chr 6:12,716,767...13,287,837
Ensembl chr 6:12,716,312...13,290,446
G
PIGA
phosphatidylinositol glycan anchor biosynthesis class A
IAGP
HPO
ORPHA:447
NCBI chr X:15,319,451...15,335,554
Ensembl chr X:15,319,452...15,335,554
G
PITX2
paired like homeodomain 2
IAGP
HPO
ORPHA:334
NCBI chr 4:110,617,423...110,642,123
Ensembl chr 4:110,617,423...110,642,123
G
PLAU
plasminogen activator, urokinase
IAGP
DNA:SNP:3' utr:c.*141C>T (rs4065)
RGD
PMID:20518747
RGD:6484126
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PTGIS
prostaglandin I2 synthase
susceptibility
IAGP
DNA:SNP::1117C>A DNA:silent mutation:exon 8:1117C>A DNA:SNP:CDS: (rs5629)
RGD
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748
RGD:401901147 , RGD:401901268 , RGD:401901155 , RGD:2313891
NCBI chr20:49,503,874...49,568,137
Ensembl chr20:49,503,874...49,568,137
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
IAGP
HPO
ORPHA:500
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
RAF1
Raf-1 proto-oncogene, serine/threonine kinase
IAGP
HPO
ORPHA:500
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
G
RFC2
replication factor C subunit 2
IAGP
HPO
ORPHA:904
NCBI chr 7:74,231,502...74,254,399
Ensembl chr 7:74,231,499...74,254,458
G
SCN1B
sodium voltage-gated channel beta subunit 1
IAGP
HPO
ORPHA:334
NCBI chr19:35,030,470...35,040,449
Ensembl chr19:35,030,470...35,040,449
G
SCN2B
sodium voltage-gated channel beta subunit 2
IAGP
HPO
ORPHA:334
NCBI chr11:118,162,806...118,176,639
Ensembl chr11:118,162,806...118,176,639
G
SCN3B
sodium voltage-gated channel beta subunit 3
IAGP
HPO
ORPHA:334
NCBI chr11:123,629,188...123,654,624
Ensembl chr11:123,629,187...123,655,244
G
SCN4B
sodium voltage-gated channel beta subunit 4
IAGP
HPO
ORPHA:334
NCBI chr11:118,133,377...118,152,823
Ensembl chr11:118,133,377...118,152,888
G
SCN5A
sodium voltage-gated channel alpha subunit 5
IAGP
HPO
ORPHA:334
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,743
G
SCNN1A
sodium channel epithelial 1 subunit alpha
IAGP
HPO
ORPHA:60033
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
G
SCNN1B
sodium channel epithelial 1 subunit beta
IAGP
HPO
ORPHA:60033
NCBI chr16:23,278,231...23,381,294
Ensembl chr16:23,278,231...23,381,294
G
SCNN1G
sodium channel epithelial 1 subunit gamma
IAGP
HPO
ORPHA:60033
NCBI chr16:23,182,745...23,216,883
Ensembl chr16:23,182,745...23,216,883
G
SH2B3
SH2B adaptor protein 3
IAGP
HPO
MIM:133100 ORPHA:3318
NCBI chr12:111,404,730...111,451,623
Ensembl chr12:111,405,923...111,451,623
G
SLC2A10
solute carrier family 2 member 10
IAGP
HPO
ORPHA:3342
NCBI chr20:46,708,320...46,736,347
Ensembl chr20:46,709,649...46,736,347
G
STAT4
signal transducer and activator of transcription 4
IAGP
HPO
ORPHA:117
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
STX1A
syntaxin 1A
IAGP
HPO
ORPHA:904
NCBI chr 7:73,699,210...73,719,669
Ensembl chr 7:73,699,206...73,719,672
G
TBL2
transducin beta like 2
IAGP
HPO
ORPHA:904
NCBI chr 7:73,567,537...73,578,579
Ensembl chr 7:73,567,537...73,578,791
G
TET2
tet methylcytosine dioxygenase 2
IAGP
HPO
ORPHA:3318
NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816
G
THOC2
THO complex subunit 2
IAGP
HPO
ORPHA:457240
NCBI chr X:123,600,569...123,733,052
Ensembl chr X:123,600,561...123,733,056
G
TLR4
toll like receptor 4
IAGP
HPO
ORPHA:117
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TMEM270
transmembrane protein 270
IAGP
HPO
ORPHA:904
NCBI chr 7:73,860,848...73,865,890
Ensembl chr 7:73,861,159...73,865,890
G
TP53
tumor protein p53
IAGP
HPO
ORPHA:3318 ORPHA:96253
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TTN
titin
IAGP
HPO
ORPHA:334
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
UBAC2
UBA domain containing 2
IAGP
HPO
ORPHA:117
NCBI chr13:99,200,854...99,386,504
Ensembl chr13:99,200,774...99,386,504
G
USP48
ubiquitin specific peptidase 48
IAGP
HPO
ORPHA:96253
NCBI chr 1:21,678,298...21,783,149
Ensembl chr 1:21,678,298...21,783,606
G
USP8
ubiquitin specific peptidase 8
IAGP
HPO
ORPHA:96253
NCBI chr15:50,424,405...50,514,421
Ensembl chr15:50,424,380...50,514,421
G
VHL
von Hippel-Lindau tumor suppressor
IAGP
HPO
ORPHA:892
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,676
G
VPS37D
VPS37D subunit of ESCRT-I
IAGP
HPO
ORPHA:904
NCBI chr 7:73,665,347...73,672,110
Ensembl chr 7:73,667,831...73,672,112
G
WRN
WRN RecQ like helicase
IAGP
HPO
ORPHA:902
NCBI chr 8:31,033,810...31,176,138
Ensembl chr 8:31,033,788...31,176,138
G
ZMPSTE24
zinc metallopeptidase STE24
IAGP
HPO
ORPHA:740
NCBI chr 1:40,258,236...40,294,180
Ensembl chr 1:40,258,041...40,294,180
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all